Source comparison
Gain Lean Muscle Mass with Peptides: Compound Comparison
CJC-1295 (no DAC) GHRH analog. Stimulates pituitary GH release in pulses 100–200 mcg, 2–3× weekly 30 minutes Increases IGF-1 by 200–300% when stacked with GHRPs; minimal standalone hypertrophy data Foundational compound. Primes GH axis but requires GHRP co-adm
This comparison does not assign a generated winner or score.
- CJC-1295 (no DAC)
- GHRH analog. Stimulates pituitary GH release in pulses
- 100–200 mcg, 2–3× weekly
- 30 minutes
- Increases IGF-1 by 200–300% when stacked with GHRPs; minimal standalone hypertrophy data
- Foundational compound. Primes GH axis but requires GHRP co-administration for measurable muscle gains
- CJC-1295 (with DAC)
- Modified GHRH analog with extended release
- 2 mg once weekly
- 6–8 days
- Similar IGF-1 elevation but sustained trough levels risk receptor desensitization
- Convenient dosing but less flexible for cycling; better for maintenance than aggressive hypertrophy protocols
- Ipamorelin
- GHRP. Ghrelin receptor agonist with high selectivity
- 200–300 mcg, 2–3× daily
- 2 hours
- 12-week trials show 2.1–3.2 kg lean mass gains when combined with CJC-1295 and resistance training
- Gold standard GHRP. Minimal side effects, no cortisol spike, ideal for long-term use
- Hexarelin
- GHRP. Potent ghrelin receptor agonist
- 100 mcg, 2–3× daily
- 70 minutes
- Strongest acute GH response (5–15× baseline), but 8–12 week ceiling before desensitization
- Powerful short-term gains but requires strict cycling; not suitable for continuous protocols
- MK-677 (Ibutamoren)
- Oral ghrelin mimetic (not a peptide)
- 10–25 mg once daily
- 24 hours
- Increases IGF-1 by 60–90%; 8-week trials show 1.1 kg lean mass gain vs placebo
- Convenient oral dosing but constant GH elevation causes water retention and may impair insulin sensitivity long-term
- GHRP-2
- GHRP. Less selective than ipamorelin
- 100–200 mcg, 2–3× daily
- 20 minutes
- Comparable IGF-1 elevation to ipamorelin but elevates cortisol and prolactin 30–50%
- Effective but cortisol spike negates some anabolic benefit; ipamorelin preferred unless cost is prohibitive